In line with previous observations, STAT3-Tyr705 phosphorylation occurred in both HEL and SET2 BP-MPN cell lines, and DYRK1A inhibition led to a dose-dependent reduction in STAT3-Tyr705 phosphorylation. Here, SETD2 is linked to myeloproliferative disorder.